Model
Edge
Lyell Immunopharma Inc.
0001866154
Filing Type
4
Filing Date
3/17/2022
Updated
3/18/22, 10:05 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership